Sunovion Pharmaceuticals signs on at Glenpointe
On Dec. 14, Alfred Sanzari Enterprises said it secured a new lease with a Massachusetts-based pharmaceutical company at its Glenpointe corporate campus.
Sunovion Pharmaceuticals Inc.’s deal covers 24,000 square feet of office space, according to that company. It expects to begin occupancy in early 2022.
“With support of the Alfred Sanzari team we are able to take advantage of designing an innovative new space to enhance the work experience for our employees in New Jersey and the tri-state area,” said Sunovion Senior Vice President and Chief Human Resources Officer Linda Arsenault. “Glenpointe provides us with a dynamic, efficient, and flexible workspace that aligns with being a best place to work, with amenities and offerings for employees in this important region for our business.”
